Get the Stockscreener App
15.40
2.90%
-0.46
After Hours:
15.35
-0.05
-0.32%
Avadel Pharmaceuticals Plc stock is traded at $15.40, with a volume of 1.46M.
It is down -2.90% in the last 24 hours and up +14.93% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$15.86
Open:
$15.75
24h Volume:
1.46M
Relative Volume:
1.03
Market Cap:
$1.50B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
308.00
EPS:
0.05
Net Cash Flow:
$5.89M
1W Performance:
-2.28%
1M Performance:
+14.93%
6M Performance:
+93.47%
1Y Performance:
+10.43%
1-Day Range:
$15.37
$15.81
1-Week Range:
$15.00
$16.04
52-Week Range:
$6.38
$16.66
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
15.40 | 1.54B | 221.08M | -2.92M | 5.89M | 0.05 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
150,451 Shares in Avadel Pharmaceuticals PLC. $AVDL Acquired by Cubist Systematic Strategies LLC - MarketBeat
HC Wainwright Brokers Lift Earnings Estimates for AVDL - MarketBeat
Avadel: LUMRYZ Momentum And Pipeline Expansion Support Buy Rating - Seeking Alpha
Two Seas Capital LP Raises Stock Position in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Invenomic Capital Management LP Takes Position in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Trexquant Investment LP Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Analysts Set Expectations for AVDL Q3 Earnings - MarketBeat
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
165,520 Stock Options: Avadel Pharmaceuticals Grants Major Inducement Awards to New Key Hires - Stock Titan
Russell Investments Group Ltd. Reduces Stock Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Given New $36.00 Price Target at HC Wainwright - MarketBeat
What is Lifesci Capital's Estimate for AVDL Q2 Earnings? - MarketBeat
What is the earnings history of Avadel Pharmaceuticals plcMarket Volume Summary & Safe Entry Trade Reports - Lancaster City Council
Lifesci Capital Upgrades Avadel Pharmaceuticals (NASDAQ:AVDL) to Strong-Buy - MarketBeat
Avadel (AVDL) Licenses Valiloxybate and Unveils LUMRYZ Data at World Sleep 2025 - Yahoo Finance
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap DownHere's What Happened - MarketBeat
Is Avadel Pharmaceuticals plc currently under institutional pressure2025 Buyback Activity & Detailed Earnings Play Strategies - beatles.ru
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Multi Factor Analysis Ranks Avadel Pharmaceuticals plc as Strong BuyDividend Hike & Stepwise Trade Signal Implementation - beatles.ru
Avadel chief commercial officer resigns, stock down 14% - MSN
Will Avadel Pharmaceuticals plc continue its uptrendStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - Newser
Insider Stock Buying Reaches US$761.7k On Avadel Pharmaceuticals - 富途牛牛
Caption Management LLC Buys 104,910 Shares of Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Smart tools for monitoring Avadel Pharmaceuticals plc’s price actionQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersCEO Change & Daily Profit Maximizing Tips - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsPortfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Avadel Pharmaceuticals at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com UK
Avadel Pharmaceuticals Presents 17 Abstracts on LUMRYZ Efficacy at World Sleep 2025, Highlighting Benefits of Once-Nightly Sodium Oxybate for Narcolepsy Treatment - Quiver Quantitative
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - The Manila Times
Avadel to Present LUMRYZ Narcolepsy Data at World Sleep 2025 | AVDL Stock News - Stock Titan
Predicting Avadel Pharmaceuticals plc trend using moving averagesJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Avadel Pharmaceuticals stock price target raised to $36 at H.C. Wainwright - Investing.com UK
Is Avadel Pharmaceuticals plc stock ready for a breakout2025 Market Outlook & Reliable Breakout Forecasts - Newser
Applying Elliott Wave Theory to Avadel Pharmaceuticals plcJobs Report & High Accuracy Swing Entry Alerts - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityWeekly Volume Report & Daily Price Action Insights - Newser
Published on: 2025-09-04 22:28:10 - Newser
The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com India
Avadel Pharmaceuticals plc Testing Reversal Zone on Weekly ChartDividend Hike & Free Fast Entry Momentum Trade Alerts - beatles.ru
Avadel Pharmaceuticals (AVDL) Attracts Institutional Investment - MSN
Why Avadel Pharmaceuticals plc is moving todayJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Avadel licenses once-at-bedtime oxybate therapy from XWPharma By Investing.com - Investing.com Australia
Avadel secures rights to develop valiloxybate globally - Yahoo Finance
Sleep Disorder Market Heats Up with Avadel’s Global Grab for Valiloxybate - geneonline.com
Will Avadel Pharmaceuticals plc rebound enough to break evenJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Can you recover from losses in Avadel Pharmaceuticals plcWeekly Loss Report & Low Drawdown Investment Ideas - Newser
How to read the order book for Avadel Pharmaceuticals plcTrade Risk Report & Weekly Sector Rotation Insights - Newser
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):